What Comes After GLP-1? Multi-Hormone Peptide Research Explained | Infinite Longevity
Infinite LongevityPublished on: 06/09/2026
GLP-1 changed metabolic medicine, but it is only one hormone pathway. Learn why researchers are now studying dual and triple agonists, amylin combinations, and compounds such as tirzepatide, retatrutide, and CagriSema.
what comes after GLP-1Multi-hormone peptidesGLP-1 and GIPGLP-1 glucagon agonistTriple agonist peptideTirzepatide vs retatrutideCagrilintideCagriSemaAmylin weight loss researchMulti-receptor obesity drugs